AFP and neoplasm: Following completion of five chemotherapy cycles, the tumor marker levels showed marked reduction: AFP 78 ng/mL, CEA 189 ng/mL, CA15.3–46 U/mL, CA125–20 U/mL, and CA19.9–59 U/mL.